The Enalapril 20mg tablets will face further supply disruption until mid-end of October 2020, the Department of Health and Social Care (DHSC) has said.
The DHSC further said that alternate strengths of Enalapril (2.5mg, 5mg, and 10mg) tablets remain available and will be able to support increased demand for the drug.
Unlicensed supplies of Enalapril 20mg tablets can be sourced to avert any supply shortages.
The following specialist importers have confirmed they can source unlicensed Enalapril 20mg tablets.
- Alium Medical
- Clinigen Group
- Durbin PLC
- Mawdsley’s Unlicensed
- Target Healthcare, and
- Waymade PLC
There is currently no listing on dm+d for the imported product for prescribers to select using their prescribing systems so an EPS prescription for unlicensed Enalapril 20mg tablets cannot be issued.
If a prescriber wishes to prescribe an unlicensed import, an FP10 paper prescription should be issued as ‘Enalapril 20mg tablets (Special Order)‘ and endorsed by the pharmacy as a non-Part VIIIB special.
